Ania Jastreboff, MD, PhD, has co-authored numerous research studies on dual- and triple-receptor hormone agonists, including retatrutide
Another key compound available is Semaglutide , a GLP-1 receptor agonist widely examined in metabolic and biochemical research settings
The biggest selling point of peptides is cognitive performance enhancement: Peptides can increase concentration and energy levels through improved mitochondrial efficiency, improve stress resistance (e.g., via cortisol modulation), and positively influence sleep and recovery
Clinical studies show that semaglutide reduces A1c by approximately 1.01.5 percentage points in patients with type 2 diabetes
Your diabetes has improved, blood pressure normalized, sleep apnea resolved, or other measurable health gains make ongoing treatment clearly worthwhile
Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial